TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 59 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $12,840,000 | +11.1% | 12,905,000 | +8.4% | 0.01% | -6.7% |
| Q3 2020 | $11,554,000 | +18.1% | 11,905,000 | +17.8% | 0.02% | +15.4% |
| Q2 2020 | $9,786,000 | -65.0% | 10,105,000 | -66.6% | 0.01% | -45.8% |
| Q1 2020 | $27,960,000 | +95.3% | 30,210,000 | +100.0% | 0.02% | +41.2% |
| Q4 2019 | $14,318,000 | +4.7% | 15,105,000 | 0.0% | 0.02% | -5.6% |
| Q3 2019 | $13,677,000 | +170862.5% | 15,105,000 | +167733.3% | 0.02% | – |
| Q2 2018 | $8,000 | +100.0% | 9,000 | +125.0% | 0.00% | – |
| Q1 2018 | $4,000 | -99.9% | 4,000 | -99.9% | 0.00% | -100.0% |
| Q4 2017 | $3,044,000 | -83.1% | 3,469,000 | -82.6% | 0.01% | -85.0% |
| Q3 2017 | $18,005,000 | -26.5% | 19,978,000 | -12.5% | 0.04% | -29.8% |
| Q2 2017 | $24,480,000 | -1.1% | 22,825,000 | -0.9% | 0.06% | -3.4% |
| Q1 2017 | $24,740,000 | -34.0% | 23,041,000 | -32.7% | 0.06% | -37.9% |
| Q4 2016 | $37,479,000 | -11.2% | 34,227,294 | -3.2% | 0.10% | -19.5% |
| Q3 2016 | $42,192,000 | -5.1% | 35,362,986 | -0.3% | 0.12% | -33.7% |
| Q2 2016 | $44,437,000 | +36.1% | 35,461,705 | +41.3% | 0.18% | +31.9% |
| Q1 2016 | $32,650,000 | +8.4% | 25,091,762 | +30.1% | 0.14% | +8.0% |
| Q4 2015 | $30,112,000 | +12.1% | 19,287,222 | -2.7% | 0.12% | +12.6% |
| Q3 2015 | $26,872,000 | +7.7% | 19,813,878 | +10.9% | 0.11% | +20.7% |
| Q2 2015 | $24,957,000 | -5.2% | 17,858,417 | +0.4% | 0.09% | -3.2% |
| Q1 2015 | $26,327,000 | +37.7% | 17,788,935 | +27.1% | 0.10% | +35.7% |
| Q4 2014 | $19,116,000 | +6.5% | 13,991,660 | +0.0% | 0.07% | -48.1% |
| Q3 2014 | $17,955,000 | -21.8% | 13,985,539 | -22.1% | 0.14% | -13.5% |
| Q2 2014 | $22,954,000 | -14.5% | 17,957,869 | -15.1% | 0.16% | -14.3% |
| Q1 2014 | $26,858,000 | +45.6% | 21,158,825 | +21.8% | 0.18% | +40.0% |
| Q4 2013 | $18,443,000 | -14.2% | 17,368,021 | -16.2% | 0.13% | -15.6% |
| Q3 2013 | $21,485,000 | – | 20,722,132 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |